Epiterna
PrivateLast Round
Seed
Aug 1, 2023
Total Funding Raised
$11M
Company Overview
Epiterna is a biotechnology company that develops medicinal products aimed at treating diseases in both animals and humans, utilizing a drug screening platform to create solutions that safely slow aging, prevent age-related diseases, and delay functional decline, ultimately helping users to extend their lives.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epiterna Comps
Public and private peers based on sector, stage, and business model.
Epiterna Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 1, 2023 |
Epiterna Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Prima Materia | Seed |
Epiterna Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Epiterna's valuation, stock price, and market status.
